The Journal of Experimental Medicine
BioSymposia
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online October 22, 2007
doi:10.1084/jem.20062610
The Journal of Experimental Medicine, Vol. 204, No. 11, 2747-2757
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Yachi et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yachi, P. P.
Right arrow Articles by Gascoigne, N. R.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yachi, P. P.
Right arrow Articles by Gascoigne, N. R.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

T cell activation enhancement by endogenous pMHC acts for both weak and strong agonists but varies with differentiation state

Pia P. Yachi, Carina Lotz, Jeanette Ampudia, and Nicholas R.J. Gascoigne

Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

CORRESPONDENCE Nicholas R.J. Gascoigne: gascoigne{at}scripps.edu

T cells are extremely sensitive in their ability to find minute amounts of antigenic peptide in the midst of many endogenous peptides presented on an antigen-presenting cell. The role of endogenous peptides in the recognition of foreign peptide and hence in T cell activation has remained controversial for CD8+ T cell activation. We showed previously that in a CD8+ T cell hybridoma, nonstimulatory endogenous peptides enhance T cell sensitivity to antigen by increasing the coreceptor function of CD8. However, others were not able to detect such enhancement in naive and activated CD8+ T cells. Here, we show that endogenous peptides substantially enhance the ability of T cells to detect antigen, an effect measurable by up-regulation of activation or maturation markers and by increased effector function. This enhancement is most pronounced in thymocytes, moderate in naive T cells, and mild in effector T cells. The importance of endogenous peptides is inversely proportional to the agonist activity of the stimulatory peptide presented. Unlike for CD4+ T cells, the T cell receptor of CD8+ T cells does not distinguish between endogenous peptides for their ability to enhance antigen recognition.


Abbreviations used: APL, altered peptide ligand; cSMAC, central supramolecular activation cluster; DP, double-positive; IS, immunological synapse(s); Kb, H-2Kb; MFI, mean fluorescent intensity; pMHC, peptide–MHC; VSV, vesicular stomatitis virus.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS